Carl Ashley Morris
Net Worth

Last updated:

What is Carl Ashley Morris net worth?

The estimated net worth of Dr. Carl Ashley Morris is at least $3,324,716 as of 27 Jan 2023. He owns shares worth $115,596 as insider, has earned $472,120 from insider trading and has received compensation worth at least $2,737,000 in Solid Biosciences Inc..

What is the salary of Carl Ashley Morris?

Dr. Carl Ashley Morris salary is $547,400 per year as Chief Scientific Officer in Solid Biosciences Inc..

How old is Carl Ashley Morris?

Dr. Carl Ashley Morris is 55 years old, born in 1970.

What stocks does Carl Ashley Morris currently own?

As insider, Dr. Carl Ashley Morris owns shares in one company:

Company Title Shares Price per share Total value
Solid Biosciences Inc. (SLDB) Chief Scientific Officer 19,760 $5.85 $115,596

What does Solid Biosciences Inc. do?

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

SLDB logo
SLDB
Solid Biosciences Inc.
$5.85

Carl Ashley Morris insider trading

Solid Biosciences Inc.

Dr. Carl Ashley Morris has made 7 insider trades between 2020-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 23,398 units of SLDB stock on 12 Mar 2021. As of 27 Jan 2023 he still owns at least 19,760 units of SLDB stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 1,233 N/A N/A
Option
Restricted Stock Units 1,233 N/A N/A
Sale
Common Stock 441 $7.49 $3,303
Sale
Common Stock 11,396 $1.1 $12,536
Sale
Common Stock 11,269 $1.1 $12,396
Sale
Common Stock 23,398 $8.85 $206,979
Sale
Common Stock 23,398 $8.85 $206,979
Sale
Common Stock 3,459 $6.14 $21,238
Option
Common Stock 11,500 N/A N/A
Option
Restricted Stock Units 11,500 N/A N/A
Sale
Common Stock 3,591 $2.42 $8,690
Option
Common Stock 11,500 N/A N/A
Option
Restricted Stock Units 11,500 N/A N/A

Solid Biosciences key executives

Solid Biosciences Inc. executives and other stock owners filed with the SEC: